Composition
- Active ingredients
- POSACONAZOLE 40MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- POSACONAZOLE 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseNDA205053-001 · Discontinued
- POSACONAZOLE 40MG/ML · SuspensionNDA022003-001 · Prescription
- POSACONAZOLE 40MG/ML · SuspensionThis page
- POSACONAZOLE 300MG/16.7ML (18MG/ML) · SolutionNDA205596-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022027.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Noxafil
- Active substance
- posaconazole
- Route
- Oral
- Dosage form
- Suspension
- Applicant
- Schering
- Status
- Prescription
- FDA approval
- 20 Oct 2006
- Application
- NDA022027-001



